Cargando…

Sensitivity to change and minimal clinically important difference of the angioedema control test

BACKGROUND: The Angioedema Control Test (AECT) is a patient‐reported outcome measure developed and validated for the assessment of disease control in patients with recurrent angioedema. Its sensitivity to change and minimal clinically important difference (MCID) have hitherto not been established. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fijen, Lauré M., Vera, Carolina, Buttgereit, Thomas, Bonnekoh, Hanna, Maurer, Marcus, Magerl, Markus, Weller, Karsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472988/ https://www.ncbi.nlm.nih.gov/pubmed/37746798 http://dx.doi.org/10.1002/clt2.12295

Ejemplares similares

Case report: Recurrent angioedema: Diagnosing the rare and the frequent
por: Buttgereit, Thomas, et al.
Publicado: (2022)

Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change
por: Kulthanan, Kanokvalai, et al.
Publicado: (2019)

Patient‐physician interactions in hereditary angioedema—Key learnings from the coronavirus disease 2019 pandemic
por: Maurer, Marcus, et al.
Publicado: (2023)

Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell–Mediated Angioedema
por: Maurer, Marcus, et al.
Publicado: (2021)

COVID-19 vaccination and the risk of swellings in patients with hereditary angioedema
por: Fijen, Lauré M., et al.
Publicado: (2021)

Impact of lanadelumab on health‐related quality of life in patients with hereditary angioedema in the HELP study
por: Lumry, William R., et al.
Publicado: (2020)

Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies
por: Aygören-Pürsün, Emel, et al.
Publicado: (2018)

Current and Prospective Targets of Pharmacologic Treatment of Hereditary Angioedema Types 1 and 2
por: Fijen, Lauré M., et al.
Publicado: (2021)

Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria – Results from the validation of the Polish Urticaria Control Test()
por: Brzoza, Zenon, et al.
Publicado: (2022)

Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe
por: Zanichelli, Andrea, et al.
Publicado: (2013)

Outcome measures in randomized controlled studies of acute therapy for hereditary angioedema: A systematic review
por: Fijen, Lauré M., et al.
Publicado: (2022)

Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients
por: Kulthanan, Kanokvalai, et al.
Publicado: (2019)

Inhibition of interleukin‐1 with rilonacept is not effective in cold urticaria—Results of a randomized, placebo‐controlled study
por: Bonnekoh, Hanna, et al.
Publicado: (2023)

Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema
por: Vanya, Magdalena, et al.
Publicado: (2023)

WAO Guideline for the Management of Hereditary Angioedema
por: Craig, Timothy, et al.
Publicado: (2012)

Correction to: Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema
por: Vanya, Magdalena, et al.
Publicado: (2023)

Attenuated androgen discontinuation in patients with hereditary angioedema: a commented case series
por: Maurer, Marcus, et al.
Publicado: (2022)

Long‐term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study
por: Banerji, Aleena, et al.
Publicado: (2021)

Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey
por: Zanichelli, Andrea, et al.
Publicado: (2018)

Patient-reported Outcome Measures for Angioedema: A Literature Review
por: BRIX, Anna Trier Heiberg, et al.
Publicado: (2021)

A novel histopathological scoring system to distinguish urticarial vasculitis from chronic spontaneous urticaria
por: Puhl, Viktoria, et al.
Publicado: (2021)

Assessment of disease activity and quality of life in patients with recurrent bradykinin-mediated versus mast cell-mediated angioedema()
por: Can, Pelin Kuteyla, et al.
Publicado: (2021)

Could it be hereditary angioedema?—Perspectives from different medical specialties
por: Magerl, Markus, et al.
Publicado: (2023)

A Germany-wide survey study on the patient journey of patients with hereditary angioedema
por: Magerl, Markus, et al.
Publicado: (2020)

Management of patients with hereditary angioedema in Germany: comparison with other countries in the Icatibant Outcome Survey
por: Maurer, M., et al.
Publicado: (2018)

Skin and Systemic Inflammation in Schnitzler's Syndrome Are Associated With Neutrophil Extracellular Trap Formation
por: Bonnekoh, Hanna, et al.
Publicado: (2019)

Clinical Utility Gene Card for hereditary angioedema with normal C1 inhibitor (HAEnC1)
por: Stieber, Christiane, et al.
Publicado: (2017)

Correction to: A Germany-wide survey study on the patient journey of patients with hereditary angioedema
por: Magerl, Markus, et al.
Publicado: (2021)

Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)
por: Parsopoulou, Faidra, et al.
Publicado: (2022)

The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks
por: Longhurst, Hilary J., et al.
Publicado: (2016)

The Severe Asthma Questionnaire: sensitivity to change and minimal clinically important difference
por: Masoli, Matthew, et al.
Publicado: (2021)

Angioedema and prescribing of omalizumab for chronic urticaria in countries with limited financial resources
por: Popov, Todor A., et al.
Publicado: (2019)

Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies
por: Bonner, Nicola, et al.
Publicado: (2015)

Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema
por: Bygum, Anette, et al.
Publicado: (2017)

Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT)
por: Kulthanan, Kanokvalai, et al.
Publicado: (2016)

Comparing acquired angioedema with hereditary angioedema (types I/II): findings from the Icatibant Outcome Survey
por: Longhurst, H. J., et al.
Publicado: (2017)

Angioedema
por: Kaplan, Allen P
Publicado: (2008)

Omalizumab rapidly improves angioedema‐related quality of life in adult patients with chronic spontaneous urticaria: X‐ACT study data
por: Staubach, P., et al.
Publicado: (2017)

Minimal changes in health status questionnaires: distinction between minimally detectable change and minimally important change
por: de Vet, Henrica C, et al.
Publicado: (2006)

Management of urticarial vasculitis: A worldwide physician perspective()
por: Kolkhir, Pavel, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_srm0ug5ckipk0s4jneggp2iq6f